GlobeNewswire by notified

Worksoft Acquires AI-Powered SaaS Test Automation Platform eureQa


Addition of Performance and Mobile Testing Capabilities to Leading Process Intelligence and Test Automation Platform Expands Packaged Application Breadth and Delivery Flexibility

ADDISON, Texas, May 23, 2022 (GLOBE NEWSWIRE) -- Worksoft, leading provider of end-to-end intelligent process automation for complex custom and packaged applications, announced today the acquisition of eureQa, an AI-powered SaaS test automation platform purpose-built for testing digital applications. eureQa’s no-code performance and end-to-end testing of web, mobile, API, database and packaged applications expands Worksoft’s Connective Automation platform capabilities, delivering a comprehensive automation platform to help organizations understand, de-risk and optimize end-to-end business processes.

With expectations and competition higher than ever, ensuring superior end-user experiences has become a critical differentiator for organizations across every industry. To compete, organizations need the ability to analyze, validate and optimize the entire customer journey across applications. eureQa’s AI-powered SaaS platform verifies customer-facing business processes and e-commerce sites perform as expected across all browsers, operating systems and mobile devices. This combined with Worksoft’s process intelligence and test automation capabilities will ensure organizations can protect and maximize the value of their investments regardless of the technology or industry.

With eureQa, Worksoft will now offer enhanced performance, mobile and API testing, offering a complete automation platform to customers who are looking to modernize systems at speed and scale without sacrificing quality. Customers will have the flexibility to align to cloud, on-premise or hybrid delivery, allowing them to choose the right model to support their unique strategic initiatives.

"eureQa has developed an exceptional platform, and we’re excited to welcome the team to the Worksoft family,” said Tony Sumpster, CEO, Worksoft. “The addition of eureQa’s AI-driven SaaS testing platform and its additional strengths in performance and mobile testing expands our offering to provide a robust platform that looks holistically across your business and technology investments to ensure quality and deliver tangible automation ROI.”

eureQa’s cloud-native cross-platform solution uses AI/ML techniques to support self- healing tests and autonomous troubleshooting for B2C and B2B customer facing e-commerce sites to reduce risk for new implementations, business process change, or compliance needs, delivering optimal performance for end users across all devices and browsers.

“Providing outstanding end-to-end digital experiences for customers is becoming increasingly critical to our success,” said Badri Nittoor, Founder and CEO of eureQa. “Our combined capabilities provide customers with a flexible, resilient platform supporting validation and execution across the enterprise application landscape, enabling enterprises to accelerate release speed, reduce defects, and elevate user experiences.”

To learn more, please join eureQa and Worksoft for a joint webinar highlighting how this combined solution will revolutionize how enterprises apply and deploy end-to-end automation to optimize business processes to future proof from continuous change and accelerate transformation.

About Worksoft

Worksoft provides Connective Automation for world leading global enterprises, automating the full lifecycle of a business process from process intelligence to testing to RPA. Our codeless automation empowers business users and IT to create and accelerate automation and arms organizations with 360-degree process insights to prioritize and speed test automation creation and reuse in production for maximum efficiency and scalability. With Worksoft, enterprises can accelerate project timelines and ensure data-driven quality for complex end-to-end custom and enterprise applications, including SAP, Oracle, Salesforce, Workday®, SuccessFactors, ServiceNow, and more. Recognized by analysts and top Systems Integrators (SI) as amarket leader for SAP testing, Worksoft is embedded into leading SI ERP practices to enable their Agile, DevOps, and SAFe methodologies and accelerate transformation initiatives. For more information, visit

About eureQa

eureQa is the digital assurance platform purpose built for testing digital applications for today’s leading global companies. With eureQa, companies can be confident their users get the best experience on their digital applications across all devices and browsers. eureQa provides end-to-end testing for Web UI, Mobile Apps, API and databases. With AI to accelerate automation, and machine learning to power self-healing, resilient tests with automatic root cause analysis, eureQa enables teams to stay ahead of testing demands. By running functional, API, performance and compatibility tests on a unified platform companies can deliver great digital experiences with confidence. For more information, visit

For media inquiries, contact Liz Blackman,, or +1 (972) 993-0400.

A photo accompanying this announcement is available at

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release

REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens

Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release

24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri

Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release

With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au

Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo

Cool Company Ltd. – Mandatory Notification Of Trade24.6.2022 11:01:19 CEST | Press release

EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 23 June 2022 acquired 7,865 shares in the Company at a price of NOK 90.274882 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,591,218 shares in the Company, equivalent to 38.97% of the Company’s shares. Please see the attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form